• Mashup Score: 0
    Time's A Wasting - 9 month(s) ago

    The ALS clock is running.  In the next few weeks, the FDA will make a decision regarding approval of NurOwn for ALS. Either way, another tri…

    Tweet Tweets with this article
    • Same trial. If you start it today, it's called a Ph 3 trial. If wait to start it until after an approval, it's called a Ph 4 confirmatory trial. The sooner it starts, the sooner it finishes. https://t.co/a2xbF1953a

  • Mashup Score: 1
    Time's A Wasting - 10 month(s) ago

    The ALS clock is running.  In the next few weeks, the FDA will make a decision regarding approval of NurOwn for ALS. Either way, another tri…

    Tweet Tweets with this article
    • Either way, another trial is needed, so let's get moving! https://t.co/a2xbF1953a https://t.co/UXH6bx1wSx

  • Mashup Score: 0

    It’s pretty basic.  You can’t make good decisions without good data. And a core decision in moving ahead with any project is to weigh the …

    Tweet Tweets with this article
    • B4 we spend another dime on CDC ALS Registry, we need a functional accounting of how they spent the last $10,000,000. This is basic to good business decisions. Why wont CDC provide? Why wont ALS orgs insist? Why oh why? https://t.co/lq7ptIfWcR https://t.co/lwBZsIrOLk

  • Mashup Score: 0

    A little over a week ago we got the wonderful news that a drug had been approved for ALS in the US.  Since then we have had multiple news…

    Tweet Tweets with this article
    • Back to 2017. We couldn't get any patient advocacy organizations to even talk about it, so here we are. And if you throw up your hands and say patient advocacy organizations can't affect price, look at some parents of children w serious diseases. https://t.co/yK3ivtnLIw 4/end https://t.co/6D720J96vH